According to Coya Therapeutics's latest financial reports the company has โน2.68 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | โน0.49 B | 52% |
2021-12-31 | โน0.32 B | -49.35% |
2020-12-31 | โน0.63 B |